scholarly journals Use of Tri-Chloroacetic Acid /Acetone/polyethylene glycol for protein purification from HIV-1 infected human plasma

2019 ◽  
Author(s):  
Sushanta Kumar Barik ◽  
Keshar Kunja Mohanty ◽  
Deepa Bisht ◽  
Partha Sarathi Mohanty ◽  
Shripad Patil ◽  
...  

Abstract Human plasma contains high amount of abundant proteins like albumin and globulin. Normally, the proteins having potential for biomarkers are present in very low concentration in human plasma. To resolve the low concentration proteins in polyacrylamide gel, the removal of high abundant proteins from plasma are very essential. Polyethylene glycol is a nontoxic, water soluble synthetic polymer has several applications in chemical and biomedical industries. Various molecular variants of poly ethylene glycol is available and used in protein purification. The mechanism behind the use of high concentration of polyethylene glycol is it binds the molecule in more compact or interpenetrates forming a gel like network surrounding the molecule. Polyethylene glycol -6000 removes the high abundant proteins like Albumin and Globulin in the HIV -1 infected plasma samples and concentrates the low molecular weight proteins as the low molecular weight proteins are essential in biomarker study.

2019 ◽  
Vol 35 (4(102)) ◽  
pp. 5-40
Author(s):  
Adam Daragó ◽  
Andrzej Sapota ◽  
Marek Jakubowski

Cadmium (Cd) is a white metal with a bluish tint. It forms a number of compounds occurring in them on the degree of oxidation 2+. Cadmium compounds are water-soluble to varying degrees. The highest risk groups include employees involved in the production of nickel-cadmium batteries, alloys, cadmium pigments as well as employees of non-ferrous metal smelters and cutting welders of metals covered with a cadmium anti-corrosion layer. According to the Central Register of Data on Exposure to Substances , Preparations, Factors or Technological Processes on Carcinogenic or Mutagenic Action, 4276 workers in Poland were exposed to cadmium and its compounds. Cadmium is absorbed into the body through inhalation and digestive systems. In humans, the absorption is 2–50% and 4–6%, respectively. Elimination of cadmium from the body is a slow process. The estimated half-life of cadmium is from 5 to 30 years. Results of studies conducted in subjects exposed to cadmium in the work environment showed that the threshold concentration of cadmium in urine, at which increased excretion of low molecular weight proteins in urine was found, is 5–10 µg/g creatinine. In 1993, IARC identified cadmium and its compounds as a human carcinogen (group 1). The results of experimental studies in rats provided evidence of cadmium carcinogenicity as a result of inhalation exposure. Cadmium is recognized by SCOEL as a category C carcinogen, i.e. as a genotoxic carcinogen for which a threshold of action (concentration) can be determined, also called a practical threshold. The critical organs for the toxic effects of cadmium and its inorganic compounds in humans, depending on the route of exposure, are kidneys, lungs and possibly bones. The critical effect of cadmium on kidneys is increased excretion of low molecular weight proteins in urine, while the critical effect on lungs is the carcinogenic effect. Inhalation studies in rats exposed to cadmium at concentrations of 30 µgCd/m3, 13.4 µgCd/m3 and 10 µgCd/m3 for 18 months were used as the basis to propose TLV-TWA. The concentration of 10 µg Cd/m3 was taken as the NOAEL value. After applying the formula and taking into account the uncertainty factors with a total value of 10, the concentration of 0.001 mg/m3 (1 µgCd/m3) was determined as the TLV-TWA value for the inhaled fraction. Biological monitoring is the best indicator of cadmium exposure. The excretion of cadmium in urine enables the assessment of cumulative cadmium in the body and takes into account all sources of cadmium exposure, including contaminated food and smoking, while the blood cadmium concentration is a measure of current exposure. Previous BEI values in blood and urine were 5 μgCd/l and 5 μgCd/g creatinine, respectively. After discussion at the 91st meeting of the Interministerial Committee for TLVs and PELs, these values were maintained as mandatory. This article discusses the problems of occupational safety and health, which are covered by health sciences and environmental engineering.


2013 ◽  
Vol 13 (3) ◽  
Author(s):  
Netty Widyastuti ◽  
Teguh Baruji ◽  
Henky Isnawan ◽  
Priyo Wahyudi ◽  
Donowati Donowati

Beta glucan is a polysaccharide compound, generally not soluble inwater and resistant to acid. Beta glucan is used as an immunomodulator (enhancing the immune system) in mammals is usually a beta-glucan soluble in water, easily absorbed and has a low molecular weight. Several example of beta-glucan such as cellulose (β-1 ,4-glucan), lentinan (β-1 0.6-glucan) and (β-1 ,3-glucan), pleuran (β-1, 6 and β-1 ,3-glucan) are isolated from species of fungi Basidiomycota include mushrooms (Pleurotus ostreatus) and shiitake (Lentinus edodes).The purpose of thisresearch activity is to obtain beta-glucan compound that can be dissolved in water and in alkali derived from fungi Basidiomycota, i.e, Oyster mushrooms (Pleurotus ostreatus) and shiitake (Lentinus edodes). The result of beta-glucan compared to characterize the resulting beta glucan that is molecular structure . The difference of beta glucan extraction is based on the differences in solubility of beta-glucan. Beta glucan could be water soluble and insoluble water.


2020 ◽  
Vol 26 (8) ◽  
pp. 802-814 ◽  
Author(s):  
Nemanja Turkovic ◽  
Branka Ivkovic ◽  
Jelena Kotur-Stevuljevic ◽  
Milica Tasic ◽  
Bojan Marković ◽  
...  

Background: Since the beginning of the HIV/AIDS epidemic, 75 million people have been infected with the HIV and about 32 million people have died of AIDS. Investigation of the molecular mechanisms critical to the HIV replication cycle led to the identification of potential drug targets for AIDS therapy. One of the most important discoveries is HIV-1 protease, an enzyme that plays an essential role in the replication cycle of HIV. Objective: The aim of the present study is to synthesize and investigate anti-HIV-1 protease activity of some chalcone derivatives with the hope of discovering new lead structure devoid drug resistance. Methods: 20 structurally similar chalcone derivatives were synthesized and their physico-chemical characterization was performed. Binding of chalcones to HIV-1 protease was investigated by fluorimetric assay. Molecular docking studies were conducted to understand the interactions. Results: The obtained results revealed that all compounds showed anti-HIV-1 protease activity. Compound C1 showed the highest inhibitory activity with an IC50 value of 0.001 μM, which is comparable with commercial product Darunavir. Conclusion: It is difficult to provide general principles of inhibitor design. Structural properties of the compounds are not the only consideration; ease of chemical synthesis, low molecular weight, bioavailability, and stability are also of crucial importance. Compared to commercial products the main advantage of compound C1 is the ease of chemical synthesis and low molecular weight. Furthermore, compound C1 has a structure that is different to peptidomimetics, which could contribute to its stability and bioavailability.


1965 ◽  
Vol 240 (7) ◽  
pp. 2868-2876 ◽  
Author(s):  
T. Ikenaka ◽  
D. Gitlin ◽  
K. Schmid

1985 ◽  
Vol 260 (2) ◽  
pp. 695-698
Author(s):  
J T Westwood ◽  
E B Wagenaar ◽  
R B Church

Sign in / Sign up

Export Citation Format

Share Document